Search
News Archive
Categories
Archive for May, 2010
The Sixth National Chitin-Chitosan Conference (6th NCCC) will be held on August 26-27, 2010 in Bangkok, Thailand
Posted On: May 14, 2010The Sixth National Chitin-Chitosan Conference (6th NCCC) will be held on August 26-27, 2010 in Bangkok, Thailand in conjunction with the 6th Thailand Materials Science and Technology Conference and Thailand Textile Symposium 2010. This conference has been jointly-organized by the Center for Chitin-Chitosan Biomaterials (CCB), Metallurgy and Materials Science Research Institute (MMRI), Chulalongkorn University and the National Metal and Materials Technology Center (MTEC).
Aker BioMarine, Lipogen Come Together To Develop Phospholipids Formula
Posted On: May 14, 2010Aker BioMarine, an integrated biotechnology company positioned to create value from krill harvesting and processing and Lipogen, a producer of the functional cognitive ingredient phosphatidylserine (PS), have joined forces to develop a phospholipids formula for cognitive health.
Aker BioMarine and Lipogen said that the target formula is a matrix of Lipogen PS phosphatidylserine produced from Aker BioMarine’s pure Superba Krill Oil. Reportedly, Phosphatidylserine (PS) and omega-3 fatty acids are both key components of the brain’s cell membranes. The new ingredient could either be applied together with multivitamins or as a single ingredient targeting brain health.
Final Program Available for Marine Biodiscovery Event in the UK, June 2010
Posted On: May 14, 2010This meeting, coinciding with the opening of the new £1.6M Marine Biodiscovery Centre, will address the potential for new products and processes from the marine environment, with a particular emphasis on the technical challenges and realising successful outcomes. This will cover novel pharmaceuticals and high value chemicals such as biomaterials, nutraceuticals and personal care products as well as novel enzymes with unique activities. Academic and industrial aspects will be presented and there will be a showcase for Scottish companies and facilities.
Research Shows Chemicals from Seaweed Can Kill Coral
Posted On: May 14, 2010Field studies have shown for the first time that several common species of seaweeds in both the Pacific and Caribbean Oceans can kill corals upon contact using chemical means.
While competition between seaweed and coral is just one of many factors affecting the decline of coral reefs worldwide, this chemical threat may provide a serious setback to efforts aimed at repopulating damaged reefs. Seaweeds are normally kept in check by herbivorous fish, but in many areas overfishing has reduced the populations of these plant-consumers, allowing seaweeds to overpopulate coral reefs.
A study documenting the chemical effects of seaweeds on corals was scheduled to be published May 10, 2010 in the early edition of the journal Proceedings of the National Academy of Sciences (PNAS). The research was supported by the National Institutes of Health, the National Science Foundation, and the Teasely Endowments at the Georgia Institute of Technology.
Maxomega-90 Omega-3 Launch: A ‘Blank Canvas’ For Formulators
Posted On: May 7, 2010Scottish firm Equateq announces today that high-end nutraceutical companies can now provide their customers with almost any ratio of EPA and DHA omega oil concentrates they want, with the launch of Maxomega-90, a range that exploits pharmaceutical sector separation methods to deliver omega-3 EPA and DHA in any 90% combination, Equateq announced today.
‘We say that Maxomega-90 is like a blank canvas, allowing companies to mix lipid actives in almost any combination they require,’ explained Equateq CEO Adam Kelliher. ‘This will enable companies to define their product rationale and give a more clear, and focused offering.’
Lipid specialist Equateq is unique in using industrial-scale chromatography to make lipid concentrates, in preference to the usual industry method of distillation. The Maxomega ™ process can separate all key lipids at up to 99% purity, but these super-high levels are mostly used by pharmaceutical companies and researchers. The Maxomega-90 range is geared for the nutritional sector, allowing delivery of EPA and DHA in any ratio, from 80/10 to 10/80, with each offering always having at least 90% total omega-3.
Marine Ingredients Poised For Accelerated Development
Posted On: May 6, 2010Inside Cosmeceuticals posted an editorial feature we recently wrote on the future for Marine Ingredients. Read more below:
————————
Many believe the ocean is where life first started. Then it is no surprise, perhaps, that the biggest potential source for new, bioactive ingredients for the health and beauty market may originate from the same place. With so many new species of marine life still to be discovered, the potential for new marine-derived compounds and extracts is immense, and the industry is poised for accelerated development in the near future.
Later this year, the final results of the Census of Marine Life will be revealed. This 10-year ambitious initiative, driven by a global network of researchers in about 80 nations, is intended to assess and explain the diversity, distribution and abundance of marine life in the world’s oceans. This massive study will tell us about newly identified marine organisms and marine life not previously known. This news is exciting, as new promising bacteria, organisms and compounds will be likely discovered, providing a potential treasure trove of new marine ingredient products.
Australian Scientists In Swine Flu Breakthrough with Seaweed
Posted On: May 5, 2010In a breakthrough that offers new hope for the containment of influenza outbreaks, an Australian biotechnology company has isolated a natural extract from seaweed which has been shown to inhibit the H1N1 virus.
The extract – known as Maritech® 926 – is a fucoidan compound derived from the Undaria pinnatifida species of seaweed. In vitro tests performed under contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in the US, have shown that Maritech® 926 can inhibit the H1N1 influenza virus at extremely low concentrations.
Developed by biotechnology company Marinova Pty Ltd, Maritech® 926 is a natural polysaccharide which has immediate market potential in nutritional supplements, hand washes and nasal delivery products which target the spread and prevention of viral conditions. Scope also exists for the compound to be included in pharmaceutical and medical device applications. As a result of these findings, Marinova has filed for patent protection over the application of Maritech® 926 and other fucoidan extracts in a range of anti-viral applications.
UNCW Center for Marine Science to Host Innovation Workshop for State’s Marine Research Community April 28, 2010
Posted On: May 4, 2010The University of North Carolina Wilmington Center for Marine Science is bringing together research scientists, university administrators, government leaders, members of innovation centers and business people from around the state for a collaborative workshop on permanent innovation from 9 a.m. to 4 p.m. Wednesday, April 28 at the Center for Marine Science. The workshop will be facilitated by Langdon Morris, a recognized expert and author of the book, “Permanent Innovation.”
The workshop is NOT open to the general public, but media are welcome to attend and cover the event. About 135 participants are expected from across North Carolina.
The workshop’s purpose is to introduce the principles of permanent innovation to the center’s community of associated universities, government agencies and businesses, and to enable this community to improve its performance as a leading source of innovation and economic development for North Carolina. Accelerated innovation will be critical to support a general shift away in the state’s economy away from tobacco and manufacturing, and toward knowledge-related activities
Aker BioMarine signs first agreement for Superba Krill in Asia
Posted On: May 4, 2010Aker BioMarine has signed a distributor agreement with Compson Trade Co., Ltd for the Taiwanese market. This is the first step into the Asian market for Superba Krill and a milestone for Aker BioMarine.
“We are proud to work with a company like Compson Trade, and they have so far impressed us with their ambitions, dedication and high level of competence”, says Matts Johansen, Executive Vice President in Aker BioMarine.
Compson Trade was founded 15 years ago by Charlie Wu, and has through it’s focus on marketing, innovation, quality and customer service, grown to the leading supplier of dietary and pharmaceutical material in Taiwan. Aker BioMarine’s Superba Krill will with its new agreement have the best possible position to have success in Tawian.
New Microalgal Strain Found with High PUFA Levels
Posted On: May 4, 2010Ben-Gurion University of the Negev (BGU) researchers have isolated a microalgal strain which produces large amounts of a polyunsaturated fatty acid that could reduce blood pressure, chronic inflammation and blood cholesterol level, reducing the risk for heart attacks.
A research team at BGU’s Landau Family Microalgal Biotechnology Lab in the Jacob Blaustein Institutes for Desert Research (BIDR) headed by Prof. Zvi HaCohen, is studying an algal mutant that is capable of accumulating up to 15 percent (of dry weight) of a polyunsaturated fatty acid (PUFA) called DGLA (Dihomo-γ-Linolenic Acid). The new strain, IKG-1, is a freshwater microalga that the researchers believe is the only known plant source capable of producing such significant amounts of DGLA.
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
